Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on LI 3. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111484424A reveals a copper-catalyzed route for Omacycline intermediates, offering drastic solvent reduction and superior isomer control for pharmaceutical manufacturing.
Novel patent CN115466214B offers safer route for Valicarb intermediate. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN106831563A reveals metal-free carbon-nitrogen catalyst for quinoline synthesis, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel metal-free synthesis of 6-fluoroimidazo[1,2-a]pyridine-3-carboxylic acid offers high purity and scalable production for pharmaceutical intermediates.
Patent CN119431279B reveals a novel Ir-catalyzed asymmetric hydrogenation route for chiral cyclic ethers, offering superior purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN116396204A reveals a safe, scalable isatin-based route for 4,6,7-trifluoro-1H-indole-2-carboxylic acid, replacing explosive azide chemistry with high-purity outcomes.
Patent CN108997247A discloses efficient oxidation route for Rivaroxaban intermediate enabling cost reduction in API manufacturing and supply chain reliability.
Patent CN114349687B reveals metal-free asymmetric hydrogenation. Enhances safety and reduces costs for pharmaceutical intermediates manufacturing supply chains.
Novel water/ethanol synthesis of 5-(aryl methylene) Michaelis acid. High yield, eco-friendly, scalable process for pharmaceutical intermediates.
Novel patent CN105085395B improves bedaquiline intermediate yield and purity significantly reducing manufacturing costs and enhancing supply chain reliability for global pharmaceutical partners.
Novel Lewis acid catalyzed synthesis offers high purity trans-isomer selectivity for pharmaceutical intermediate manufacturing supply chains and significant cost efficiency.
Patent CN106518939A reveals a cost-effective Solithromycin route avoiding azides. Enhances supply chain reliability and purity for pharmaceutical intermediates.
Patent CN116396201A details a safe, scalable DeoxoFluor route for (2R,4R)-4-fluoropyrrolidine-2-carboxylic acid, offering significant cost and safety advantages over traditional DAST methods.
Novel one-step synthesis patent CN103319335B offers high purity greater than 99 percent. Reduces equipment investment and enables green manufacturing for pharmaceutical intermediates.
Advanced manufacturing of (S)-4-isobutyl-dihydro-3H-furan-2-one via a novel Grignard route. Offers significant cost reduction and scalable production for pharmaceutical intermediates.
Patent CN104803905A reveals high-yield palladium catalysis. Enhances supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing globally.
Novel cobalt-catalyzed synthesis of imidazolidinones from polyols and amidines. Green, scalable process for pharmaceutical intermediates with cost advantages.
Novel patent CN106831756B offers high-yield Aclidinium Bromide synthesis. Reduces costs and ensures supply chain stability for COPD pharmaceutical manufacturing.
Patent CN114456121A reveals a catalyst-free photochemical route to 1,2,4-triazoles using blue LEDs, offering significant cost reduction and greener manufacturing for pharmaceutical intermediates.
Novel synthesis route for Tamiflu intermediate avoiding toxic selenium. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.